Therapeutic advances in psychopharmacology

How easy to understand are consent forms for ketamine trials in mental health

Updated

Abstract

The readability of informed consent forms in ketamine-based psychiatric trials is systematically evaluated.

  • Informed consent forms are essential for ethical clinical research, especially in psychiatry.
  • Cognitive and emotional symptoms in psychiatric patients can affect their ability to understand consent documents.
  • The evaluation focuses on the clarity and comprehensibility of consent materials used in studies involving ketamine.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Damian Swieczkowski: No conflict of interest. Aleksander Kwaśny: (i) grants: Beckley Psytech, GH Research, MSD. Wiesław Jerzy Cubała: (i) grants/research support: Acadia, Alkermes, Allergan, Auspex Pharmaceuticals, BMS, Celon, Cephalon, Cortexyme, Ferrier, Forest Laboratories, Gedeon Richter, GW Pharmaceuticals, KCR, Lilly, Lundbeck, Minerva, NIH, Orion, Servier. (ii) honoraria: Adamed, AstraZeneca, BMS, Celon, GSK, KRKA, Lekam, Lundbeck, Minerva, NeuroCog, Orion, Pfizer, Polfa Tarchomin, Sanofi, Servier, Zentiva, Recognify Life Sciences. (iii) advisory boards: Celon (terminated), Sanofi. (iv) consultant: Douglas Pharmaceuticals, GH Research, Janssen. The authors declare that potential conflicts of interest have been disclosed. These conflicts had no role in the study design, data collection, analysis, interpretation, or the decision to submit the article for publication.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free